301 related articles for article (PubMed ID: 9208945)
1. DNA interactions of bifunctional dinuclear platinum(II) antitumor agents.
Zaludová R; Zákovská A; Kasparková J; Balcarová Z; Kleinwächter V; Vrána O; Farrell N; Brabec V
Eur J Biochem; 1997 Jun; 246(2):508-17. PubMed ID: 9208945
[TBL] [Abstract][Full Text] [Related]
2. Effect of geometric isomerism in dinuclear platinum antitumor complexes on DNA interstrand cross-linking.
Kaspárková J; Nováková O; Vrána O; Farrell N; Brabec V
Biochemistry; 1999 Aug; 38(34):10997-1005. PubMed ID: 10460154
[TBL] [Abstract][Full Text] [Related]
3. Sequence-dependent conformational changes in DNA induced by polynuclear platinum complexes.
McGregor TD; Balcarová Z; Qu Y; Tran MC; Zaludová R; Brabec V; Farrell N
J Inorg Biochem; 1999 Oct; 77(1-2):43-6. PubMed ID: 10626352
[TBL] [Abstract][Full Text] [Related]
4. Cellular pharmacology of polynuclear platinum anti-cancer agents.
Roberts JD; Peroutka J; Farrell N
J Inorg Biochem; 1999 Oct; 77(1-2):51-7. PubMed ID: 10626354
[TBL] [Abstract][Full Text] [Related]
5. DNA modifications by a novel bifunctional trinuclear platinum phase I anticancer agent.
Brabec V; Kaspárková J; Vrána O; Nováková O; Cox JW; Qu Y; Farrell N
Biochemistry; 1999 May; 38(21):6781-90. PubMed ID: 10346899
[TBL] [Abstract][Full Text] [Related]
6. Comparison of cytotoxicity and cellular accumulation of polynuclear platinum complexes in L1210 murine leukemia cell lines.
Roberts JD; Peroutka J; Beggiolin G; Manzotti C; Piazzoni L; Farrell N
J Inorg Biochem; 1999 Oct; 77(1-2):47-50. PubMed ID: 10626353
[TBL] [Abstract][Full Text] [Related]
7. DNA interactions of new cytotoxic tetrafunctional dinuclear platinum complex trans,trans-[{PtCl2(NH3)}2(piperazine)].
Brabec V; Christofis P; Slámová M; Kostrhunová H; Nováková O; Najajreh Y; Gibson D; Kaspárková J
Biochem Pharmacol; 2007 Jun; 73(12):1887-900. PubMed ID: 17400194
[TBL] [Abstract][Full Text] [Related]
8. Sequence specificity, conformation, and recognition by HMG1 protein of major DNA interstrand cross-links of antitumor dinuclear platinum complexes.
Kasparkova J; Farrell N; Brabec V
J Biol Chem; 2000 May; 275(21):15789-98. PubMed ID: 10747955
[TBL] [Abstract][Full Text] [Related]
9. Biophysical analysis of natural, double-helical DNA modified by a dinuclear platinum(II) organometallic compound in a cell-free medium.
Marini V; Kasparkova J; Novakova O; Monsú Scolaro L; Romeo R; Brabec V
J Biol Inorg Chem; 2002 Sep; 7(7-8):725-34. PubMed ID: 12203009
[TBL] [Abstract][Full Text] [Related]
10. DNA binding by antitumor trans-[PtCl2(NH3)(thiazole)]. Protein recognition and nucleotide excision repair of monofunctional adducts.
Kasparkova J; Novakova O; Farrell N; Brabec V
Biochemistry; 2003 Jan; 42(3):792-800. PubMed ID: 12534292
[TBL] [Abstract][Full Text] [Related]
11. DNA interactions of antitumor trans-[PtCl2(NH3)(quinoline)].
Zákovská A; Nováková O; Balcarová Z; Bierbach U; Farrell N; Brabec V
Eur J Biochem; 1998 Jun; 254(3):547-57. PubMed ID: 9688265
[TBL] [Abstract][Full Text] [Related]
12. DNA interactions of antitumor cisplatin analogs containing enantiomeric amine ligands.
Malina J; Hofr C; Maresca L; Natile G; Brabec V
Biophys J; 2000 Apr; 78(4):2008-21. PubMed ID: 10733979
[TBL] [Abstract][Full Text] [Related]
13. Modification of natural, double-helical DNA by antitumor cis- and trans-[Cl(2)(Me(2)SO(4))(4)Ru] in cell-free media.
Nováková O; Hofr C; Brabec V
Biochem Pharmacol; 2000 Dec; 60(12):1761-71. PubMed ID: 11108791
[TBL] [Abstract][Full Text] [Related]
14. Trifunctional dinuclear platinum complexes as DNA-protein cross-linking agents.
Kloster M; Kostrhunova H; Zaludova R; Malina J; Kasparkova J; Brabec V; Farrell N
Biochemistry; 2004 Jun; 43(24):7776-86. PubMed ID: 15196020
[TBL] [Abstract][Full Text] [Related]
15. Sequence specificity of DNA-DNA interstrand cross-link formation by cisplatin and dinuclear platinum complexes.
Zou Y; Van Houten B; Farrell N
Biochemistry; 1994 May; 33(18):5404-10. PubMed ID: 8180163
[TBL] [Abstract][Full Text] [Related]
16. Translesion DNA synthesis across double-base lesions derived from cross-links of an antitumor trinuclear platinum compound: primer extension, conformational and thermodynamic studies.
Novakova O; Farrell NP; Brabec V
Metallomics; 2018 Jan; 10(1):132-144. PubMed ID: 29242879
[TBL] [Abstract][Full Text] [Related]
17. DNA interactions of cisplatin tethered to the DNA minor groove binder distamycin.
Loskotová H; Brabec V
Eur J Biochem; 1999 Dec; 266(2):392-402. PubMed ID: 10561579
[TBL] [Abstract][Full Text] [Related]
18. Antitumor bifunctional dinuclear Pt(II) complex BBR3535 forms interduplex DNA cross-links under molecular crowding conditions.
Muchova T; Quintal SM; Farrell NP; Brabec V; Kasparkova J
J Biol Inorg Chem; 2012 Feb; 17(2):239-45. PubMed ID: 21938443
[TBL] [Abstract][Full Text] [Related]
19. DNA interactions of a novel platinum drug, cis-[PtCl(NH3)2(N7-acyclovir)]+.
Balcarová Z; Kaspárková J; Zákovská A; Nováková O; Sivo MF; Natile G; Brabec V
Mol Pharmacol; 1998 May; 53(5):846-55. PubMed ID: 9584210
[TBL] [Abstract][Full Text] [Related]
20. DNA interactions of new antitumor aminophosphine platinum(II) complexes.
Neplechová K; Kaspárková J; Vrána O; Nováková O; Habtemariam A; Watchman B; Sadler PJ; Brabec V
Mol Pharmacol; 1999 Jul; 56(1):20-30. PubMed ID: 10385680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]